Johnson Johnson Stock Performance
| JNJ Stock | USD 155.40 0.88 0.57% |
The company retains a Market Volatility (i.e., Beta) of 0.21, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Johnson Johnson's returns are expected to increase less than the market. However, during the bear market, the loss of holding Johnson Johnson is expected to be smaller as well. At this point, Johnson Johnson has a negative expected return of -0.0876%. Please make sure to check out Johnson Johnson's maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Johnson Johnson performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The newest stock price chaos, may contribute to medium-term losses for the stakeholders. ...more
Actual Historical Performance (%)
One Day Return 1.31 | Five Day Return 0.42 | Year To Date Return (2.14) | Ten Year Return 44.62 | All Time Return 70 K |
Forward Dividend Yield 0.0321 | Payout Ratio 0.4795 | Last Split Factor 2:1 | Forward Dividend Rate 4.96 | Dividend Date 2024-12-10 |
| Johnson Johnson dividend paid on 10th of September 2024 | 09/10/2024 |
1 | Insider Trading | 11/08/2024 |
2 | First National Trust Co Decreases Holdings in Johnson Johnson | 11/13/2024 |
3 | Acquisition by Woods Eugene A. of 261 shares of Johnson Johnson subject to Rule 16b-3 | 11/18/2024 |
4 | STAT Pharmalittle Were reading about Pfizers new RD head, Merck and JJ job cuts in China, and more | 11/20/2024 |
5 | Spotlight on Johnson Johnson Analyzing the Surge in Options Activity | 11/21/2024 |
6 | Nwam LLC Purchases Shares of 33,196 Johnson Johnson | 11/22/2024 |
7 | Dr Borehams Crucible The rise and rise of LTR Pharma | 11/25/2024 |
| Begin Period Cash Flow | 14.1 B | |
| Total Cashflows From Investing Activities | 878 M |
Johnson |
Johnson Johnson Relative Risk vs. Return Landscape
If you would invest 16,454 in Johnson Johnson on August 30, 2024 and sell it today you would lose (914.00) from holding Johnson Johnson or give up 5.55% of portfolio value over 90 days. Johnson Johnson is generating negative expected returns assuming volatility of 0.7866% on return distribution over 90 days investment horizon. In other words, 7% of stocks are less volatile than Johnson, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Johnson Johnson Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Johnson Johnson's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Johnson Johnson, and traders can use it to determine the average amount a Johnson Johnson's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1114
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | JNJ |
Estimated Market Risk
| 0.79 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Johnson Johnson is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Johnson Johnson by adding Johnson Johnson to a well-diversified portfolio.
Johnson Johnson Fundamentals Growth
Johnson Stock prices reflect investors' perceptions of the future prospects and financial health of Johnson Johnson, and Johnson Johnson fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Johnson Stock performance.
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.084 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 390.51 B | ||||
| Shares Outstanding | 2.41 B | ||||
| Price To Earning | 24.69 X | ||||
| Price To Book | 5.35 X | ||||
| Price To Sales | 4.24 X | ||||
| Revenue | 85.16 B | ||||
| Gross Profit | 63.95 B | ||||
| EBITDA | 29.34 B | ||||
| Net Income | 13.33 B | ||||
| Cash And Equivalents | 5.37 B | ||||
| Cash Per Share | 13.03 X | ||||
| Total Debt | 29.33 B | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 29.14 X | ||||
| Cash Flow From Operations | 22.79 B | ||||
| Earnings Per Share | 6.06 X | ||||
| Market Capitalization | 372.03 B | ||||
| Total Asset | 167.56 B | ||||
| Retained Earnings | 153.84 B | ||||
| Working Capital | 7.21 B | ||||
| Current Asset | 60.21 B | ||||
| Current Liabilities | 27.75 B | ||||
About Johnson Johnson Performance
By evaluating Johnson Johnson's fundamental ratios, stakeholders can gain valuable insights into Johnson Johnson's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Johnson Johnson has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Johnson Johnson has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 153.70 | 150.22 | |
| Return On Tangible Assets | 0.36 | 0.38 | |
| Return On Capital Employed | 0.19 | 0.25 | |
| Return On Assets | 0.21 | 0.14 | |
| Return On Equity | 0.51 | 0.54 |
Things to note about Johnson Johnson performance evaluation
Checking the ongoing alerts about Johnson Johnson for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Johnson Johnson help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Johnson Johnson generated a negative expected return over the last 90 days | |
| Johnson Johnson has a strong financial position based on the latest SEC filings | |
| About 73.0% of the company shares are owned by institutional investors | |
| Latest headline from stockhead.com.au: Dr Borehams Crucible The rise and rise of LTR Pharma |
- Analyzing Johnson Johnson's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Johnson Johnson's stock is overvalued or undervalued compared to its peers.
- Examining Johnson Johnson's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Johnson Johnson's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Johnson Johnson's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Johnson Johnson's stock. These opinions can provide insight into Johnson Johnson's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 4.86 | Earnings Share 6.06 | Revenue Per Share 36.428 | Quarterly Revenue Growth 0.052 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.